Evidence map›Paper›PMID 26817839›Full record

ArticleThe Journal of biological chemistry2016

Post-endocytotic Deubiquitination and Degradation of the Metabotropic γ-Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14.

Nicolas Lahaie, Michaela Kralikova, Laurent Prézeau, Jaroslav Blahos, Michel Bouvier

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Diversity of structure and function of GABAProceedings of the Japan Academy. Series B, Physical and biological sciences · 2018
    Review
  8. Regulation of G Protein-Coupled Receptors by Ubiquitination.International journal of molecular sciences · 2017
    Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Nicolas LahaieFrom the Department of Biochemistry and Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec H3T 1J4, Canada.
Michaela KralikovaInstitute of Molecular Genetics, Academy of Science of the Czech Republic, 14220 Prague 4, Czech Republic, and.
Laurent PrézeauInstitut de Génomique Fonctionnelle, Université de Montpellier 1 and 2, 34090 Montpellier, France.
Jaroslav BlahosInstitute of Molecular Genetics, Academy of Science of the Czech Republic, 14220 Prague 4, Czech Republic, and blahos@img.cas.cz.
Michel BouvierFrom the Department of Biochemistry and Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec H3T 1J4, Canada, michel.bouvier@umontreal.ca.
Czech Academy of Sciences · CZCzech Academy of Sciences, Institute of Molecular Genetics · CZInstitut de Génomique Fonctionnelle · FRInstitute for Research in Immunology and Cancer · CAUniversité de Montréal · CA

Funding

Canadian Institutes of Health Research MOP 10501
6 · The paper itself

Abstract

Mechanisms controlling the metabotropic γ-aminobutyric acid receptor (GABAB) cell surface stability are still poorly understood. In contrast with many other G protein-coupled receptors (GPCR), it is not subject to agonist-promoted internalization, but is constitutively internalized and rapidly down-regulated. In search of novel interacting proteins regulating receptor fate, we report that the ubiquitin-specific protease 14 (USP14) interacts with the GABAB(1b)subunit's second intracellular loop. Probing the receptor for ubiquitination using bioluminescence resonance energy transfer (BRET), we detected a constitutive and phorbol 12-myristate 13-acetate (PMA)-induced ubiquitination of the receptor at the cell surface. PMA also increased internalization and accelerated receptor degradation. Overexpression of USP14 decreased ubiquitination while treatment with a small molecule inhibitor of the deubiquitinase (IU1) increased receptor ubiquitination. Treatment with the internalization inhibitor Dynasore blunted both USP14 and IU1 effects on the receptor ubiquitination state, suggesting a post-endocytic site of action. Overexpression of USP14 also led to an accelerated degradation of GABABin a catalytically independent fashion. We thus propose a model whereby cell surface ubiquitination precedes endocytosis, after which USP14 acts as an ubiquitin-binding protein that targets the ubiquitinated receptor to lysosomal degradation and promotes its deubiquitination.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceBacterial ProteinsCell MembraneEndocytosisGenes, ReporterHEK293 CellsHumansHydrazonesLuciferasesLuminescent ProteinsLysosomesMolecular Sequence DataProtein BindingProtein Kinase CProteolysisBacterial ProteinsHydrazonesLuciferasesLuminescent ProteinsN'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazideProtein Kinase CReceptors, GABA-BTetradecanoylphorbol AcetateUbiquitinUbiquitin ThiolesteraseUSP14 protein, humanyellow fluorescent protein, Bacteriabioluminescence resonance energy transfer (BRET)biosensordeubiquitylation (deubiquitination)GABA receptorG protein-coupled receptor (GPCR)protein degradationreceptor endocytosisubiquitylation (ubiquitination)

Identifiers

PMID26817839
PMCPMC4807296
OpenAlexW2279631816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.